Surgical Hemostats Market | United States | 2018-2024 | MedCore

Surgical Hemostats Market | United States | 2018-2024 | MedCore

0

  • Year: 2019
  • Scope: 2015-2025
  • Region: United States
  • Pages: 540
  • Type: MedCore

In this market, there are several products approved for multiple indications and surgical specialties, which creates greater growth potential in the market. Gelatin-based hemostats represented the smallest segment in 2018, and will continue to do so through 2025. There is little innovation in this segment and the market is moving towards alternative choices.

Hemostats, also known as anti-hemorrhagic agents, are substances that promote hemostasis, the process which causes bleeding to stop. There are a number of topical hemostats used in surgeries. Topical hemostats are suitable for minor bleeding and oozing blood from injured capillaries and venules. Physiologic hemostasis occurs with vascular constriction and is a complex process in which blood changes from a fluid to a solid state to control tissue damage and bleeding. Thrombin binds to platelets and becomes activated. They activate fibrinogen into fibrin. The fibrin monomers combine to create fibrin structures that coagulate open arteries. Platelets aggregate at the injury site (the surgical incision) to form a temporary plug.

Segments Covered in This Market

  • Thrombin-Based Hemostat Market
  • Oxidized Regenerated Cellulose Hemostat Market
  • Gelatin-Based Hemostat Market
  • Collagen-Based Hemostat Market
  • Combination Hemostat Market
  • Polysaccharide-Based Hemostat Market
  • First Responder Hemostat Market

Report Data Types Included

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • 10 Year Scope (3 Year Historical + 7 Year Forecast Period)
  • Market Drivers & Limiters for Each Segment
  • Competitive Analysis with Market Shares
  • Product Portfolios
  • Related Press Releases from Top Competitors

Companies Analyzed

Of the many companies in the United States Surgical Hemostat market, Ethicon was the leader, followed by Baxter and C. R. Bard. Ethicon held a near monopoly in the ORC-based hemostat market, with their absorbable Surgicel® family of products, which are proven bactericidal agents against a broad range of both gram-positive and gram-negative bacteria. Baxter recently acquired Recothrom®, a thrombin-based hemostat, and Preveleak®, a tissue sealant, from Mallinckrodt plc. In 2013, C. R. Bard acquired Medafor for nearly $280 million, which, at the time, made them the only company in the polysaccharide-based hemostat market and improved their overall market share in the hemostat market significantly.

About Our In-Depth MedCore Research

Our analysts meticulously research for up to 3 to 4 months to put together one suite of reports (MedSuite), which is a comprehensive analysis on a group of healthcare markets. A MedCore is one portion of that analysis that focuses on one market segment, and provides further detailed segmentation to get a much more granular set of market data.

This MedCore is also found in the full report suite titled United States Market Report Suite for Wound and Tissue Management – MedSuite

Learn More about these product types



The "Surgical Hemostat Market " includes analysis on the following companies currently active in this market: Ethicon Baxter C. R. Bard Pfizer Z-Medica *Not all companies may be currently active in every segment. For more details contact an iData Research Product Advisor.




iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology


close-link
close-link

Subscribe to MedTech Market News - Get exclusive analyst articles, monthly newsletters and iData offers

close-link
close-link
close-link